Cited 15 time in
Is decreased lung function associated with chronic kidney disease? A retrospective cohort study in Korea
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Soo Kyoung | - |
| dc.contributor.author | Bae, Ji Cheol | - |
| dc.contributor.author | Baek, Jong-Ha | - |
| dc.contributor.author | Hur, Kyu Yeon | - |
| dc.contributor.author | Lee, Moon-Kyu | - |
| dc.contributor.author | Kim, Jae Hyeon | - |
| dc.date.accessioned | 2022-12-26T17:03:40Z | - |
| dc.date.available | 2022-12-26T17:03:40Z | - |
| dc.date.issued | 2018-04 | - |
| dc.identifier.issn | 2044-6055 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/11742 | - |
| dc.description.abstract | Objective There is some evidence that lung function and chronic kidney disease (CKD) may be related. We evaluated the impact of lung function on the development of CKD in a large-scale longitudinal study. Method Retrospective longitudinal analyses were conducted among subjects who participated in comprehensive health check-ups at least four times during 7 years (between 2006 and 2012). We investigated the development of CKD during the follow-up period according to lung function status. Results Ten thousand one hundred and twenty-eight individuals (mean age = 51.2 years) without CKD at baseline were enrolled. During the mean follow-up of 5 years (58.5 +/- 14.4 months), 167 of the 10 128 subjects (1.6%) developed CKD. Multivariable Cox proportional hazards analyses adjusting for age, sex, body mass index, systolic blood pressure, fasting glucose, estimated glomerular filtration rate, uric acid, triglycerides, serum albumin, and the presence of diabetes and hypertension revealed that a decrease of 10% in the forced expiratory volume in 1s (FEV1)/forced vital capacity (FVC) ratio was associated with a 35% increase in the development of CKD during the follow-up. The incidence of CKD was higher in those with an FEV1/FVC ratio < 0.8 compared with those with FEV1/FVC ratio = 0.8 (HR = 1.454; 95% CI 1.042 to 2.028, p = 0.028). Conclusions Limited airflow as measured by the FEV1/FVC ratio was associated with an increased risk of CKD. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | BMJ PUBLISHING GROUP | - |
| dc.title | Is decreased lung function associated with chronic kidney disease? A retrospective cohort study in Korea | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1136/bmjopen-2017-018928 | - |
| dc.identifier.scopusid | 2-s2.0-85057017622 | - |
| dc.identifier.wosid | 000435176700032 | - |
| dc.identifier.bibliographicCitation | BMJ OPEN, v.8, no.4 | - |
| dc.citation.title | BMJ OPEN | - |
| dc.citation.volume | 8 | - |
| dc.citation.number | 4 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | General & Internal Medicine | - |
| dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
| dc.subject.keywordPlus | OBSTRUCTIVE PULMONARY-DISEASE | - |
| dc.subject.keywordPlus | GLOMERULAR-FILTRATION-RATE | - |
| dc.subject.keywordPlus | METABOLIC SYNDROME | - |
| dc.subject.keywordPlus | MORTALITY RISK | - |
| dc.subject.keywordPlus | COMORBIDITIES | - |
| dc.subject.keywordPlus | COPD | - |
| dc.subject.keywordPlus | CKD | - |
| dc.subject.keywordAuthor | chronic renal failure | - |
| dc.subject.keywordAuthor | chronic renal insufficiency | - |
| dc.subject.keywordAuthor | Fev1/fvc | - |
| dc.subject.keywordAuthor | lung function | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
